Browsing tag

Nasim Wiegley

FOAMed

Potential Adverse Effects of SGLT2 Inhibitors in Clinical Trials

October 9, 2020

The use of SGLT2 inhibitors in patients with kidney disease is becoming the standard of care. This table covers many of the common potential side effects from several of the major clinical trials. Red- difference showing more adverse…

3 3321 0

Read Later

Topic Discussion

Kidney Replacement Therapies for Patients with Acute Neurological Injury

May 18, 2020

The incidence of acute brain injury, both ischemic and hemorrhagic stroke, is increasing in patients with end-stage kidney disease (ESKD). Risk factors include older age and co-morbidities requiring long-term systemic anticoagulation. Patients with acute traumatic brain injury develop…

14 2154 0

Read Later